JQ-1 attenuates microglial activation and retinal pathology in experimental diabetic retinopathy with modulation of Pagr1a/JAK2/STAT3 signaling.
- DOI
- 10.1016/j.intimp.2026.117428
- Published
- 2026 Sep 23
- Container
- International immunopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117428,
title = {JQ-1 attenuates microglial activation and retinal pathology in experimental diabetic retinopathy with modulation of Pagr1a/JAK2/STAT3 signaling.},
author = {Wang R and Wang L and Sun X and Zhang C and Wang B and Jiang Q and Li X and Zhu Y},
year = {2026},
journal = {International immunopharmacology},
doi = {10.1016/j.intimp.2026.117428},
url = {https://doi.org/10.1016/j.intimp.2026.117428}
}RIS
TY - JOUR TI - JQ-1 attenuates microglial activation and retinal pathology in experimental diabetic retinopathy with modulation of Pagr1a/JAK2/STAT3 signaling. AU - Wang R AU - Wang L AU - Sun X AU - Zhang C AU - Wang B AU - Jiang Q AU - Li X AU - Zhu Y PY - 2026 JO - International immunopharmacology DO - 10.1016/j.intimp.2026.117428 UR - https://doi.org/10.1016/j.intimp.2026.117428 ER -
APA
R, W., L, W., X, S., C, Z., B, W., Q, J., X, L., & Y, Z. (2026). JQ-1 attenuates microglial activation and retinal pathology in experimental diabetic retinopathy with modulation of Pagr1a/JAK2/STAT3 signaling.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117428
Source records
- pubmed · retrieved 2026-09-25T10:35:07.871Z